Find Academic Supervisors

Dr. Oluwabunmi (Bunmi) Olaloye is an Assistant Professor of Pediatrics in the Division of Neonatology at Yale School of Medicine. She holds appointments in Neonatal-Perinatal Medicine and is affiliated with the Janeway Society. Her academic background includes an MD from Rutgers New Jersey Medical School, pediatrics residency at University of Texas Medical Branch, and neonatology fellowship at University of Pittsburgh Medical Center. Dr. Olaloye's research focuses on immune dysfunction underlying neonatal intestinal diseases such as necrotizing enterocolitis (NEC) and spontaneous intestinal perforation (SIP). Using cutting-edge techniques like single-cell RNA sequencing and mass cytometry, her work identifies biomarkers and therapeutic targets to improve outcomes for premature infants. Key research areas include fetal immune system maturation, placental immune interactions, and gestational age-specific inflammatory responses. Her publication record spans 12 peer-reviewed articles between 2019-2025, emphasizing translational immunology and neonatal pathophysiology. Notable contributions include defining immune cell trajectories in preterm infants and developing gating guidelines for high-dimensional cytometry data. Current projects involve constructing immune cell atlases across human lifespans and investigating nutritional interventions for intestinal disorders. Laboratory affiliations include the Laboratory for Surgery, Obstetrics & Gynecology where she explores neonatal mucosal immunity. Her work integrates clinical observations with systems immunology approaches to address critical gaps in understanding prematurity-associated gastrointestinal pathologies.

• Neonatology
• Immunology
• Pediatric Gastroenterology
• +3 more

Katherine Elizabeth Chetta, M.D., serves as an Assistant Professor of Pediatrics in the College of Medicine at the Medical University of South Carolina (MUSC), practicing neonatology at Shawn Jenkins Children's Hospital in Charleston. Her clinical focus centers on critically ill newborns in the Neonatal Intensive Care Unit (NICU), with specialized expertise in preterm infant care and nutritional management. Dr. Chetta completed her educational journey with a B.S. in Chemistry (Honors) from the University of Kansas (2005), followed by her M.D. from Baylor College of Medicine (2009) where she earned Alpha Omega Alpha (AOA) distinction and High Honors. She completed Pediatrics Residency (2013) and Neonatology Fellowship (2016) at Baylor College of Medicine and the University of Texas Health & Science Center in Houston. Her research program investigates critical aspects of neonatal nutrition, particularly the biochemical properties of human milk and its role in preventing gastrointestinal disorders. Key focus areas include necrotizing enterocolitis (NEC) pathogenesis, free fatty acid metabolism in preterm milk, maternal vitamin D impacts on infant immunity, and quality improvement initiatives for human milk utilization. Collaborations span the Digestive Disease Research Center Core and Darby Children's Research Institute at MUSC, integrating laboratory science with clinical epidemiology. Analysis of her 15 most recent publications reveals dominant research trajectories: (1) Human milk composition and storage effects on infant outcomes, (2) NEC risk stratification through clinical/laboratory markers and imaging, (3) Social determinants of growth in preterm infants, and (4) Microbiome interactions with milk components. Her work bridges basic science (in vitro cytotoxicity studies) with clinical implementation (NICU quality improvement). Scientific recognition includes: Induction into Alpha Omega Alpha (AOA) Honor Medical Society Dr. Chetta actively collaborates with multidisciplinary teams across MUSC's research infrastructure, though specific grant details aren't provided in source materials. Her mentorship extends to medical trainees within the neonatology division, focusing on translational research methodologies. Current projects emphasize standardizing NEC diagnostic protocols and optimizing human milk feeding systems for vulnerable infants. She contributes to laboratory-based investigations at the Darby Children's Research Institute, particularly studying HAMLET complexes in human milk and their effects on intestinal cell metabolism. Her clinical work directly informs ongoing quality improvement initiatives aimed at increasing mother's own milk usage rates in the NICU.

• Neonatology
• Preterm Infant Nutrition
• Necrotizing Enterocolitis
• +3 more

Wen Lu, PhD is a Research Assistant Professor in the Department of Cell and Developmental Biology at Northwestern University's Feinberg School of Medicine. Her primary research focuses on cytoskeletal regulation and molecular motor coordination in super-large cells including oocytes and neurons, utilizing Drosophila melanogaster as a model organism. She employs high-resolution live microscopy, genetic engineering, optogenetics, and pharmacological manipulations to investigate microtubule and F-actin dynamics in cellular development and regeneration. Her educational background includes a BS from Peking University (2004) and a PhD from The University of Chicago (2010), followed by postdoctoral training at Northwestern University Feinberg School of Medicine. Dr. Lu maintains active affiliations with the American Society for Cell Biology (2019-2024) and the Genetics Society of America (2022-2023), and serves on the FlyBase Community Advisory Group since 2014. Research interests center on cytoskeletal dynamics in cellular polarization, with particular emphasis on oocyte specification, growth mechanisms, and neuronal regeneration after injury. Her work bridges developmental biology and neurobiology through innovative imaging techniques that reveal molecular transport mechanisms in cellular systems. Current investigations explore microtubule movement regulation and the interplay between cytoskeletal elements during critical developmental processes. Publication trends demonstrate strong interdisciplinary focus spanning cell biology, neurobiology, and imaging sciences, with recent work increasingly incorporating translational elements in ophthalmology and oncology. Her articles reveal consistent methodological innovation in live-cell imaging and genetic manipulation techniques applied to fundamental biological questions. Winner 2025 Drosophila Art Contest, The FlyStuff / Genesee Scientific Team Winner of CDB Graphic Design Contest, CDB Special Events Committee (2024) Winner in Category 2, Microscopy Image Competition 2024, ProteinTech Group 2nd Prize in Published Category, Microscopy Today Micrograph Awards (2024) BINA 2022 Image Contest- People's Choice Award, BioImaging North America Dr. Lu serves on the FlyBase Community Advisory Group and maintains industry relationships including ownership in Quantum Music LLC. Her laboratory work integrates advanced microscopy with genetic models to address fundamental questions in cellular organization, with potential implications for understanding developmental disorders and neurodegenerative conditions.

• Cytoskeleton
• Developmental Biology
• Neurobiology
• +4 more

Ansaf Salleb-Aouissi is a Senior Lecturer in the Department of Computer Science at Columbia University’s Fu Foundation School of Engineering and Applied Science. She holds affiliations with the Foundations of Data Science and Health Analytics centers. With a PhD from the University of Orleans, France (2003), she pursued postdoctoral training at INRIA Rennes before joining Columbia as an Associate Research Scientist in 2006. She transitioned to her current role in 2015 after serving as an adjunct professor in Computer Science and Data Science from 2014–2015. Her research focuses on machine learning applications in healthcare, education, and infrastructure systems. Key areas include medical informatics (e.g., preeclampsia prediction, genetic associations in pregnancy), educational data mining (intelligent tutoring systems, bootcamp design), and power grid reliability. Notable achievements include winning the NIH Maternal Morbidity Data Challenge and developing tools like LogicLearner for logic education. She has contributed to projects such as analyzing CDC pregnancy data and optimizing the New York City power grid. Her work bridges theoretical machine learning with real-world applications, emphasizing interpretability, bias mitigation, and collaboration across disciplines. She has published extensively in venues like JMLR, TPAMI, and ECML, addressing topics from counterfactual explanations to ensemble learning with missing data.

• Machine Learning
• Data Science
• Medical Informatics
• +4 more

Colonel David R. Stagliano, MD, is a faculty member at the Uniformed Services University of the Health Sciences (USUHS) School of Medicine, Department of Pediatrics. He currently serves as the Pediatric Infectious Diseases Fellowship Program Director at Walter Reed National Military Medical Center (WRNMMC) in Bethesda, MD. Education : Doctor of Medicine (Virginia Commonwealth University, 2003); Fellowship in Pediatric Infectious Diseases (National Capital Consortium, 2008–2011); Residency and Internship in Pediatrics (NCC, 2003–2006); Bachelor of Science in Biochemistry-Philosophy (University of Scranton, 1999, Summa Cum Laude). Dr. Stagliano’s research focuses on childhood respiratory infections , especially Respiratory Syncytial Virus (RSV) in vulnerable populations like Down syndrome patients and late-preterm infants. He also investigates tropical medicine , antimicrobial resistance (e.g., Vancomycin-Resistant Enterococcus), and clinical applications of immune plasma therapy for viral infections. His work bridges clinical practice, military deployments, and public health strategies. Selected publications highlight his contributions to travelers’ diarrhea treatment guidelines, simulation training for combat medicine, and infectious disease epidemiology in military health systems. He has deployed multiple times in support of operations in Iraq, Afghanistan, and Africa, integrating clinical expertise with operational readiness. Scientific Awards : Bronze Star Medal (OEF deployment), Defense Meritorious Service Medal, Flight Surgeon Badge, Walter Reed Master Clinician designation. As an educator, he has led the NCC Transitional Internship Program (2014–2018) and Pediatric Residency Program (2018–2021), emphasizing clinical training and infectious disease management. His military education includes advanced courses in chemical defense and tactical combat medicine.

• Pediatric Infectious Diseases
• Childhood Respiratory Infections
• Tropical Medicine
• +3 more

Pawan Kumar, BVSc, PhD is an Associate Professor in the Department of Microbiology and Immunology at Stony Brook University. His research focuses on mucosal immunology, particularly the intricate crosstalk between immune cells, microbiota, and epithelial cells that influences intestinal and extra-intestinal host defense mechanisms. Dr. Kumar's research interests include: IL-17A and mucosal host defense Th17 cell differentiation pathways IL-22 and mucosal host defense Intestinal immunity and microbiota interactions His laboratory investigates how IL-17A derived from Th17 cells plays dual roles in gastrointestinal homeostasis versus systemic autoimmunity, using intestinal epithelial cell-specific IL-17 receptor knockout mouse strains. His work on IL-22 examines its protective and inflammatory roles in inflammatory bowel disease and systemic metabolic disorders. Recent research trends show an expanding focus on how mucosal immunity interfaces with metabolic disorders, obesity, and gut-liver axis communication, demonstrating the profound connections between immune regulation and metabolic health. Dr. Kumar received his PhD from the University of Southampton, UK in 2009. His laboratory team includes postdoctoral fellows Ankita Singh and Cody Kempen, as well as undergraduate student Ruhee Damie.

• Mucosal Immunology
• IL-17A and mucosal host defense
• Th17 cell differentiation
• +3 more

David Charles Dallas is an Associate Professor at Oregon State University's College of Public Health and Human Sciences, where he serves as Endowed Director of the Moore Family Center for Whole Grain Foods, Nutrition and Preventive Health. His research program focuses on the biological functions of milk proteins and peptides, with particular emphasis on infant nutrition and digestive health. Dr. Dallas's work centers on identifying novel bioactive protein fragments in human and bovine milk, determining which milk proteins survive intact across digestion, and assessing digestive deficiencies in preterm infants. His laboratory employs clinical studies, digestion models, structural analysis techniques including peptidomics and proteomics, and functional assays to investigate how milk proteins are digested in both infants and adults. His research has revealed significant differences in digestive capacity between preterm and term infants, demonstrating that premature infants have lower ability to digest milk proteins compared to term infants. This work has important implications for improving health outcomes for preterm infants through better understanding of milk protein digestion and bioactive peptide release. Analysis of Dr. Dallas's recent publications (2023-2025) shows a strong focus on adult digestion of dairy proteins, processing techniques that preserve bioactive components, and the identification of functional milk peptides with antimicrobial and immunomodulatory properties. His work spans from basic science investigations of peptide functionality to applied research on milk processing techniques that maintain nutritional value. Dr. Dallas leads a productive research program with multiple doctoral students and has established collaborations across nutritional science, food technology, and clinical medicine fields. His work has significant implications for infant nutrition, donor human milk processing, and the development of functional dairy products for adult health.

• Milk protein digestion
• Bioactive milk peptides
• Infant nutrition
• +7 more

Matthew R. Olm is an Assistant Professor in Integrative Physiology at University of Colorado Boulder, leading the Integrative Microbiome Research Laboratory. His work combines wet-lab and computational approaches to study host-microbe interactions in inflammatory conditions. Education includes a PhD from UC Berkeley (2019) and BS from University of Pittsburgh (2014). Postdoctoral training was completed at Stanford University (2020-2024). Research examines microbiome assembly in infants, microbial contributions to necrotizing enterocolitis, and development of computational tools for strain-level microbiome analysis. His lab employs metagenomic sequencing and bioinformatic innovations. Awards include NIH F32 fellowship and recognition for high-impact publications in Cell and Science. Research has been featured in mSystems and Genome Research cover stories.

• Human Microbiome
• Mucosal Immunology
• Inflammatory Bowel Disease
• +1 more

Mae J Ciancio, Ph.D., is a Professor of Biomedical Sciences at Midwestern University, holding concurrent appointments in the College of Graduate Studies, Chicago College of Osteopathic Medicine, College of Dental Medicine-Illinois, and College of Health Sciences-Downers Grove. She serves as Program Coordinator for the Biomedical Sciences Program since 2018. Her academic credentials include a Ph.D. from Loyola University Chicago (1989), B.A. from Northwestern University (1981), and postdoctoral training at the University of Chicago Medical Center in gastroenterology. Research focuses on three primary areas: (1) anti-obesity mechanisms of heat shock protein 70 (HSP70), particularly in high-fat diet models; (2) pathogenesis of oral squamous cell carcinoma using chemically induced mouse models; and (3) HSP70's protective role against Chlamydia muridarum-induced inflammation. Notable recent work includes studies on microbiome dynamics in clinical environments and dietary impacts on cancer progression. Teaching responsibilities span courses like Research Design and Methodology , Microbiome in Health and Disease , and Seminar in Biomedical Sciences . Active grant funding includes an intramural grant investigating photobiomodulation therapy in oral cancer. Publications emphasize interdisciplinary approaches at the intersection of microbiology, physiology, and clinical science, with recent contributions in DENTAL MATERIALS , ORAL DISEASES , and PLOS ONE . Over 200 research articles demonstrate sustained productivity in translational biomedical research.

• Heat Shock Protein 70 (HSP70) research
• Obesity and metabolic disorders
• Oral squamous cell carcinoma
• +3 more

Dr. Samir K. Gadepalli is an Associate Professor of Surgery and Pediatrics at the University of Michigan Medical School , where he serves as the Daniel H. Teitelbaum M.D. Collegiate Professor. His clinical practice spans all aspects of pediatric surgery with expertise in minimally invasive procedures, neonatal surgery, hepatobiliary operations, surgical oncology, and critical care. Education: BS (Rensselaer Polytechnic Institute, 2001), MD (Albany Medical College, 2003), MBA (University of Phoenix Online, 2010), MS (University of Michigan, 2013) Dr. Gadepalli focuses on health services research to improve pediatric surgical outcomes through standardized care, evidence-based guidelines, and policy reforms. His work addresses disparities in surgical care, cost-effectiveness of interventions, and quality consortiums for conditions like inflammatory bowel disease (IBD) and necrotizing enterocolitis (NEC). His funded research includes an R01 grant from AHRQ for perianal Crohn's disease studies and PCORI grants for surgical networks like Midwest Pediatric Surgery Consortium (MWPSC) and IBD-SETON. He directs the Pediatric IBD Program and leads multidisciplinary initiatives to reduce opioid exposure post-surgery. Scientific Awards: Resident Teacher of the Year (twice), Finalist for ACS Resident Award for Exemplary Teaching (2007) Dr. Gadepalli mentors future surgeons and collaborates with families through the NEC Society and ImproveCareNow (ICN) to advance patient-centered surgical research. His work bridges clinical practice, health policy, and academic leadership.

• Pediatric Surgery
• Neonatal Surgery
• Inflammatory Bowel Disease (IBD)
• +7 more

Patricia Denning is an Adjunct Professor at the Institute for Biomedical Sciences, Georgia State University, and an Assistant Professor in neonatal-perinatal medicine at Emory University. Her research focuses on understanding the developmental regulation of intestinal innate immunity and its role in necrotizing enterocolitis (NEC) in premature infants. Her educational background includes: M.D. from Baylor College of Medicine (1991-1995) Pediatric Residency at Baylor College of Medicine (1995-1997) and Boston University Medical School (1997-1998) Clinical Neonatology Fellowship and GI Research Fellowship at Harvard Medical School (1998-2002) Dr. Denning's research centers on how immature intestinal host defenses predispose premature infants to NEC. She investigates bacterial-host interactions and the role of normal bacterial colonization in maturing intestinal innate immune responses. Her work has significant implications for developing preventive strategies against NEC, a leading cause of neonatal morbidity and mortality. Analysis of her recent publications reveals a strong focus on the interplay between gut microbiota (particularly probiotics like Lactobacillus) and intestinal immunity in neonates. Key themes include the mechanisms by which commensal bacteria and probiotics enhance host defenses, prevent NEC, and regulate inflammatory and apoptotic pathways in the developing gut. Her research spans molecular, cellular, and clinical aspects of neonatal gastrointestinal diseases. While specific laboratory or team details are not provided in the text, her extensive publication record in high-impact journals indicates an active research program investigating the developmental biology of gut immunity and NEC pathogenesis.

• Intestinal Immunology
• Neonatal Gastroenterology
• Necrotizing Enterocolitis (NEC)
• +2 more

David E. Skarda, MD, MBA, serves as Associate Professor (Clinical) in the Department of Surgery and Adjunct Assistant Professor in Pediatrics at the University of Utah School of Medicine. As a board-certified pediatric surgeon at Primary Children's Hospital (Salt Lake City and Lehi, Utah) and St. Vincent Hospital (Billings, Montana), he is the sole DaVinci robot-certified pediatric surgeon in the Intermountain West, specializing in minimally invasive and robotic techniques for children from infancy through adolescence. His educational background includes: B.S. in Molecular Biology/Chemistry from Brigham Young University M.D. from Albert Einstein College of Medicine of Yeshiva General Surgery Residency at University of Minnesota Medical Center Pediatric Surgery Fellowship at The Ohio State University - Nationwide Children's Hospital Additional fellowships in Minimally Invasive Surgery, Surgical Infectious Disease, and Surgical Critical Care Research at University of Minnesota MBA from University of Utah Dr. Skarda's clinical expertise spans elective procedures including hernia repairs, cholecystectomy, G-tube management, and robotic surgeries for reflux, MALS, SMA, and chest wall deformities, alongside emergent care for appendicitis, intestinal obstructions, and congenital anomalies. His research focuses on quality improvement in pediatric surgical outcomes , with particular emphasis on opioid stewardship, appendicitis management protocols, and health disparities. He actively employs natural language processing for surgical complication surveillance and contributes to environmental sustainability initiatives in operating rooms. Analysis of his 15 most recent publications (2019-2024) reveals consistent themes in surgical outcomes research, including: Development of evidence-based protocols for antibiotic use and CT scan reduction in appendicitis Examination of racial disparities in post-discharge surgical care Innovation in machine learning applications for infection surveillance Business and operational aspects of pediatric surgical practice Pandemic-era adaptations in surgical management Dr. Skarda collaborates extensively through national organizations including the American Academy of Pediatrics Section on Surgery and APSA Quality and Safety Committee. His leadership in multidisciplinary teams addresses complex conditions like median arcuate ligament syndrome (MALS) and superior mesenteric artery syndrome (SMA), emphasizing patient education and telemedicine accessibility. He maintains active clinical practice with 2025 patient reviews highlighting his compassionate care and thorough consultations.

• Pediatric Surgery
• Minimally Invasive Surgery
• Robotic Surgery
• +3 more

Dr. Imran Mir is an Associate Professor of Pediatrics and Program Director for the Neonatal-Perinatal Fellowship Training Program at UT Southwestern Medical School's Department of Pediatrics. His research focuses on placental biology's role in neonatal morbidities, particularly neurodevelopmental outcomes after birth asphyxia, fetal inflammatory responses, and autism spectrum disorders in preterm infants. He completed his medical training at Government Medical College in Kashmir, followed by pediatric residency at Oklahoma University and neonatal-perinatal fellowship at UT Southwestern. Education: MBBS (Government Medical College, Kashmir), Pediatric Residency (Oklahoma University), Neonatal-Perinatal Medicine Fellowship (UT Southwestern) Research emphasizes placental contributions to neonatal conditions like necrotizing enterocolitis, cerebral palsy, and congenital heart disease. Key studies include placental pathology's link to autism in preterm infants and GFAP biomarker dynamics in encephalopathy. He leads the TeleNICU initiative to improve neonatal intensive care access. Notable articles explore placental pathologies in SARS-CoV-2 pregnancies, prediction models for necrotizing enterocolitis severity, and neuroplacentology in congenital heart disease. His work integrates clinical care with precision medicine approaches for neonatal diseases.

• Placental Biology
• Neonatal Morbidities
• Neurodevelopmental Disorders
• +4 more

Nicholas Zorko, MD, PhD, is an Assistant Professor of Medicine at the University of Minnesota. His work centers on advancing NK cell-based immunotherapies for prostate and other solid tumors, with a focus on B7-H3 and PSMA-targeted tri-specific killer engagers (TriKEs). Research Interests Targeting B7-H3 and PSMA in prostate cancer immunotherapy Enhancing NK cell function in "cold" tumor microenvironments Development of off-the-shelf CAR NK cell therapies Investigating HLA class I expression and immune evasion mechanisms Scientific Contributions The 15 most recent publications (2025-2023) demonstrate expertise in tumor immunology, tri-specific antibody engineering, and pan-cancer therapeutic strategies. Key trends include optimizing radioligand therapy for prostate cancer, characterizing immune cell infiltration in solid tumors, and addressing adverse events in T-cell and NK cell therapies.

• Prostate Cancer
• Immunotherapy
• Natural Killer (NK) Cell Therapy
• +4 more

Barbara Stoll, MD is the George W Brumley Jr Professor and Chair of the Department of Pediatrics at Emory School of Medicine, and Senior Vice President and Chief Academic Officer at Children's Healthcare of Atlanta. Her work focuses on neonatal health, particularly preterm infant care, infectious diseases, and healthcare innovation. She leads major research initiatives including the NICHD Neonatal Research Network and the National Children's Study. Her clinical and translational research addresses neonatal sepsis, necrotizing enterocolitis, and neurodevelopmental outcomes. She has held leadership roles in academic medicine and pediatric healthcare systems. Key affiliations: Emory School of Medicine, Children’s Healthcare of Atlanta, Emory Children's Center Research networks: NICHD Cooperative Multicenter Neonatal Research Network Focus areas: Neonatal infections, preterm birth complications, clinical trial design Her research explores interventions for respiratory distress, liver complications in preterm infants, and optimizing neonatal care protocols. She has pioneered studies on antenatal corticosteroid use, sepsis management, and long-term neurodevelopmental outcomes. Recent work includes evaluating lipid emulsions for parenteral nutrition, analyzing sepsis biomarkers, and investigating the role of amino acid supplementation in muscle growth. She has contributed to consensus guidelines for neonatal sepsis outcomes and core measurement standards. Her leadership spans academic administration, clinical care, and translational research. She has directed major multicenter studies and collaborates with global health institutions to advance pediatric care practices.

• Pediatrics
• Neonatology
• Neonatal Intensive Care
• +6 more